Lloyd Rowland - Feb 2, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
General Counsel
Signature
/s/ Lloyd Rowland
Stock symbol
CTMX
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
4
Date filed
2/6/2023, 03:48 PM
Previous filing
Aug 12, 2022
Next filing
Mar 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Award $0 +25K +51.94% $0.00 73.1K Feb 2, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +75K $0.00 75K Feb 2, 2023 Common Stock 75K $2.59 Direct F4
transaction CTMX Performance Stock Units (PSUs) Award $0 +75K $0.00 75K Feb 2, 2023 Common Stock 75K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on Febrary 2 of each year, with the first 1/3rd vesting on February 2, 2024, subject to the Reporting Person continuing as a service provider through each such date.
F2 Includes 47,500 RSUs.
F3 Includes 4,443 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 30, 2022.
F4 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing as a service provider through each such date.
F5 Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date.